Richard S. Blumberg
Fondateur chez Syntimmune, Inc.
Profil
Richard S.
Blumberg is the founder of Bioverativ Therapeutics, Inc. (founded in 1999) and Syntimmune, Inc. (founded in 2013).
He is currently a Professor at Harvard University, a Member of the Association of American Physicians, and a Member of the American Society of Clinical Investigation.
His former positions include Chairman of Crohn's & Colitis Foundation of America and Member of the National Institutes of Health.
Blumberg's education includes an undergraduate degree from Carnegie Mellon University, a doctorate from Thomas Jefferson University, a graduate degree from Harvard University, and an MBA from Northeastern University.
Postes actifs de Richard S. Blumberg
| Sociétés | Poste | Début |
|---|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
| American Society of Clinical Investigation | Corporate Officer/Principal | - |
Association of American Physicians
 Association of American Physicians Miscellaneous Commercial ServicesCommercial Services The Association of American Physicians operates as an American association of physicians. The non-profit company is based in Tucson, AZ. The company was founded by Charles Lee. | Corporate Officer/Principal | - |
Syntimmune, Inc.
 Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA. | Fondateur | 01/01/2013 |
Anciens postes connus de Richard S. Blumberg
| Sociétés | Poste | Fin |
|---|---|---|
Crohn's & Colitis Foundation of America
 Crohn's & Colitis Foundation of America Miscellaneous Commercial ServicesCommercial Services Crohn's & Colitis Foundation of America is a non-profit organization that is run by volunteers. The non-profit company is based in New York, NY and has subsidiaries in the United States. The organization is dedicated to finding cures for Crohn's disease and ulcerative colitis, and improving the quality of life of children and adults affected by these diseases. The CEO of the company is Richard J. Geswell. | Président | - |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - |
Bioverativ Therapeutics, Inc.
 Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Fondateur | - |
Formation de Richard S. Blumberg
| Carnegie Mellon University | Undergraduate Degree |
| Harvard University | Graduate Degree |
| Thomas Jefferson University | Doctorate Degree |
| Northeastern University | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Health Technology |
Crohn's & Colitis Foundation of America
Crohn's & Colitis Foundation of America Miscellaneous Commercial ServicesCommercial Services Crohn's & Colitis Foundation of America is a non-profit organization that is run by volunteers. The non-profit company is based in New York, NY and has subsidiaries in the United States. The organization is dedicated to finding cures for Crohn's disease and ulcerative colitis, and improving the quality of life of children and adults affected by these diseases. The CEO of the company is Richard J. Geswell. | Commercial Services |
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Government |
| American Society of Clinical Investigation | |
Association of American Physicians
Association of American Physicians Miscellaneous Commercial ServicesCommercial Services The Association of American Physicians operates as an American association of physicians. The non-profit company is based in Tucson, AZ. The company was founded by Charles Lee. | Commercial Services |
Syntimmune, Inc.
Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA. | Health Technology |
